These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy. Morein D; Erlichman N; Ben-Baruch A Front Immunol; 2020; 11():952. PubMed ID: 32582148 [TBL] [Abstract][Full Text] [Related]
4. Chemokines in cancer. Chow MT; Luster AD Cancer Immunol Res; 2014 Dec; 2(12):1125-31. PubMed ID: 25480554 [TBL] [Abstract][Full Text] [Related]
5. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy. Bule P; Aguiar SI; Aires-Da-Silva F; Dias JNR Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575965 [TBL] [Abstract][Full Text] [Related]
6. Clinical utilization of chemokines to combat cancer: the double-edged sword. Dell'Agnola C; Biragyn A Expert Rev Vaccines; 2007 Apr; 6(2):267-83. PubMed ID: 17408375 [TBL] [Abstract][Full Text] [Related]
7. The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment. Susek KH; Karvouni M; Alici E; Lundqvist A Front Immunol; 2018; 9():2159. PubMed ID: 30319622 [TBL] [Abstract][Full Text] [Related]
8. The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases. Hussain S; Peng B; Cherian M; Song JW; Ahirwar DK; Ganju RK Front Immunol; 2020; 11():598532. PubMed ID: 33414786 [TBL] [Abstract][Full Text] [Related]
9. Role of chemokines in tumor growth. Raman D; Baugher PJ; Thu YM; Richmond A Cancer Lett; 2007 Oct; 256(2):137-65. PubMed ID: 17629396 [TBL] [Abstract][Full Text] [Related]
10. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer. Song N; Cui K; Zeng L; Li M; Fan Y; Shi P; Wang Z; Su W; Wang H Eur J Pharmacol; 2024 Mar; 967():176357. PubMed ID: 38309677 [TBL] [Abstract][Full Text] [Related]
11. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins. Nasser MW; Elbaz M; Ahirwar DK; Ganju RK Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive cells in tumor immune escape and metastasis. Liu Y; Cao X J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709 [TBL] [Abstract][Full Text] [Related]
13. CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting. Lee HJ; Song IC; Yun HJ; Jo DY; Kim S World J Gastroenterol; 2014 Feb; 20(7):1681-93. PubMed ID: 24587647 [TBL] [Abstract][Full Text] [Related]
14. Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization. Marcuzzi E; Angioni R; Molon B; Calì B Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30591657 [TBL] [Abstract][Full Text] [Related]
15. Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers. Jacquelot N; Duong CPM; Belz GT; Zitvogel L Front Immunol; 2018; 9():2480. PubMed ID: 30420855 [TBL] [Abstract][Full Text] [Related]
16. Immune cell recruitment and cell-based system for cancer therapy. Gao JQ; Okada N; Mayumi T; Nakagawa S Pharm Res; 2008 Apr; 25(4):752-68. PubMed ID: 17891483 [TBL] [Abstract][Full Text] [Related]
17. Chemokines and cancer: new immune checkpoints for cancer therapy. Karin N Curr Opin Immunol; 2018 Apr; 51():140-145. PubMed ID: 29579623 [TBL] [Abstract][Full Text] [Related]
18. Chemokine systems in oncology: From microenvironment modulation to nanocarrier innovations. Guan M; Liu S; Yang YG; Song Y; Zhang Y; Sun T Int J Biol Macromol; 2024 May; 268(Pt 1):131679. PubMed ID: 38641274 [TBL] [Abstract][Full Text] [Related]
19. The significance of chemokines in diffuse large B-cell lymphoma: a systematic review and future insights. Huang Q; Liu F; Shen J Future Oncol; 2019 Apr; 15(12):1385-1395. PubMed ID: 30880459 [TBL] [Abstract][Full Text] [Related]
20. The Complexity of Targeting Chemokines to Promote a Tumor Immune Response. Strazza M; Mor A Inflammation; 2020 Aug; 43(4):1201-1208. PubMed ID: 32314127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]